Dashboard
Manage Tickers

BSX

NYSE bostonscientific.com


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 629.16 $ 3.02 (0.48 %)
DIA $ 475.58 $ 0.66 (0.14 %)
SPY $ 681.80 $ 2.23 (0.33 %)
TLT $ 90.21 $ -0.27 (-0.3 %)
GLD $ 368.20 $ -2.01 (-0.54 %)
$ 100.72
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-01-2025 06-30-2025 10-Q
2 05-01-2025 03-31-2025 10-Q
3 02-18-2025 12-31-2024 10-K
4 11-01-2024 09-30-2024 10-Q
5 08-01-2024 06-30-2024 10-Q
6 05-01-2024 03-31-2024 10-Q
7 02-20-2024 12-31-2023 10-K
8 11-01-2023 09-30-2023 10-Q
9 08-03-2023 06-30-2023 10-Q
10 05-04-2023 03-31-2023 10-Q
11 02-23-2023 12-31-2022 10-K
12 11-03-2022 09-30-2022 10-Q
13 08-04-2022 06-30-2022 10-Q
14 05-05-2022 03-31-2022 10-Q
15 02-23-2022 12-31-2021 10-K
16 11-04-2021 09-30-2021 10-Q
17 08-06-2021 06-30-2021 10-Q
18 05-06-2021 03-31-2021 10-Q
19 02-23-2021 12-31-2020 10-K
20 11-05-2020 09-30-2020 10-Q
21 08-05-2020 06-30-2020 10-Q
22 05-06-2020 03-31-2020 10-Q
23 02-25-2020 12-31-2019 10-K
24 11-05-2019 09-30-2019 10-Q
25 07-30-2019 06-30-2019 10-Q
26 04-29-2019 03-31-2019 10-Q
27 02-19-2019 12-31-2018 10-K
28 10-29-2018 09-30-2018 10-Q
29 07-31-2018 06-30-2018 10-Q
30 05-01-2018 03-31-2018 10-Q
31 02-20-2018 12-31-2017 10-K
32 11-02-2017 09-30-2017 10-Q
33 08-03-2017 06-30-2017 10-Q
34 05-03-2017 03-31-2017 10-Q
35 02-23-2017 12-31-2016 10-K
36 11-03-2016 09-30-2016 10-Q
37 08-03-2016 06-30-2016 10-Q
38 05-04-2016 03-31-2016 10-Q
39 02-24-2016 12-31-2015 10-K
40 11-04-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

heres-how-much-you-would-have-made-owning-boston-scientific-stock-in-the-last-10-years
Here's How Much You Would Have Made Owning...
10/28/2025 23:30:29

what-the-options-market-tells-us-about-boston-scientific
What the Options Market Tells Us About Bos...
10/23/2025 20:01:15

truist-securities-maintains-buy-on-boston-scientific-raises-price-target-to-130
Truist Securities Maintains Buy on Boston ...
10/23/2025 14:31:42

Truist Securities analyst Richard Newitter maintains Boston Scientific (NYSE:BSX) with a Buy and raises the price target fro...

these-analysts-increase-their-forecasts-on-boston-scientific-after-upbeat-earnings
These Analysts Increase Their Forecasts On...
10/23/2025 13:41:26

wells-fargo-maintains-overweight-on-boston-scientific-raises-price-target-to-125
Wells Fargo Maintains Overweight on Boston...
10/23/2025 13:17:36

Wells Fargo analyst Larry Biegelsen maintains Boston Scientific (NYSE:BSX) with a Overweight and raises the price target fro...

morgan-stanley-maintains-overweight-on-boston-scientific-raises-price-target-to-130
Morgan Stanley Maintains Overweight on Bos...
10/23/2025 13:13:10

Morgan Stanley analyst Patrick Wood maintains Boston Scientific (NYSE:BSX) with a Overweight and raises the price target fro...

tech-stocks-drop-netflix-sinks-10-on-worst-day-since-2022-whats-moving-markets-wednesday
Tech Stocks Drop, Netflix Sinks 10% On Wor...
10/22/2025 17:47:59

Risk sentiment deteriorated sharply on Wednesday as a wave of disappointing earnings guidance and escalating U.S.-China trade t...

btig-reiterates-buy-on-boston-scientific-maintains-132-price-target
BTIG Reiterates Buy on Boston Scientific, ...
10/22/2025 17:38:57

BTIG analyst Marie Thibault reiterates Boston Scientific (NYSE:BSX) with a Buy and maintains $132 price target.

boston-scientific-gains-momentum-as-growth-broadens-goldman-sachs-says
Boston Scientific Gains Momentum As Growth...
10/22/2025 16:21:58

Goldman Sachs analyst David Roman reiterated a Buy rating and $120 price target for Boston Scientific after strong Q3 results a...

boston-scientific-jumps-on-strong-guidance-heart-devices-fuel-topline-growth
Boston Scientific Jumps On Strong Guidance...
10/22/2025 15:16:37

Boston Scientific Q3 revenue hit $5.07 billion, beating forecasts. The company raised its full-year guidance based on strong se...

boston-scientific-raises-fy2025-gaap-eps-guidance-from-189-193-to-197-201-vs-198-est
Boston Scientific Raises FY2025 GAAP EPS G...
10/22/2025 10:45:28

boston-scientific-sees-q4-gaap-eps-048-052-vs-052-est
Boston Scientific Sees Q4 GAAP EPS $0.48-$...
10/22/2025 10:45:13

boston-scientific-sees-q4-2025-adj-eps-077-079-vs-076-est-sees-sales-5220b-5310b-vs-5178b-est
Boston Scientific Sees Q4 2025 Adj EPS $0....
10/22/2025 10:44:47

boston-scientific-raises-fy2025-adj-eps-guidance-from-295-299-to-302-304-vs-298-est-fy2025--revenue-expected-to-be-around-20100b-vs-19875b-est
Boston Scientific Raises FY2025 Adj EPS Gu...
10/22/2025 10:36:39

boston-scientific-q3-2025-adj-eps-075-beats-071-estimate-sales-5065b-beat-4967b-estimate
Boston Scientific Q3 2025 Adj. EPS $0.75 B...
10/22/2025 10:31:20

Core News & Articles
Earnings Scheduled For October 22, 2025
10/22/2025 08:32:26

what-to-expect-from-boston-scientifics-earnings
What to Expect from Boston Scientific's Ea...
10/21/2025 14:02:31

21-analysts-have-this-to-say-about-boston-scientific
21 Analysts Have This To Say About Boston ...
10/17/2025 22:01:07

boston-scientifics-options-a-look-at-what-the-big-money-is-thinking
Boston Scientific's Options: A Look at Wha...
10/17/2025 19:00:43

boston-scientific-to-acquire-nalu-medical-in-600-million-pain-relief-deal
Boston Scientific To Acquire Nalu Medical ...
10/17/2025 15:02:36

Boston Scientific Corp (NYSE: BSX) to acquire Nalu Medical Inc. for $600 million in cash. Deal expected to close in first half ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION